PTC Therapeutics PTCT Intangibles (Net)
Intangibles (Net) at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.
The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTC Therapeutics's intangibles (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is PTC Therapeutics's intangibles (net)?
- PTC Therapeutics (PTCT) reported intangibles (net) of $380.68M in Q1 2026.
- How has PTC Therapeutics's intangibles (net) changed year-over-year?
- PTC Therapeutics's intangibles (net) increased by 221.4% year-over-year, from $118.45M to $380.68M.
- What is the long-term trend for PTC Therapeutics's intangibles (net)?
- Over 5 years (2020 to 2025), PTC Therapeutics's intangibles (net) has grown at a -11.5% compound annual growth rate (CAGR), from $715.33M to $388.75M.
- What does intangibles (net) mean?
- Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.